Ventriculolumbar Perfusion Chemotherapy With Methotrexate for Treating Leptomeningeal Carcinomatosis: A Phase II Study

BACKGROUND. The efficacy of ventriculolumbar perfusion (VLP) chemotherapy with methotrexate (MTX) was evaluated for treatment of leptomeningeal carcinomatosis (LMC). METHODS. The primary outcome was the response rate of increased intracranial pressure (ICP), which was available for comparison from h...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gwak, Ho-Shin, Joo, Jungnam, Shin, Sang-Hoon, Yoo, Heon, Han, Ji-Youn, Kim, Heung Tae, Yun, Tak, Ro, Jungsil, Lee, Jin Soo, Lee, Seung Hoon
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2014
Sujets:
Clinical Trial Results
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4200999/
https://ncbi.nlm.nih.gov/pubmed/25209375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0199
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires